ArticleTherapeutic advances in gastroenterology2021

Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study).

Halina Cichoż-Lach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.